StockNews.AI
RIGL
StockNews.AI
175 days

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

1. Rigel to report Q4 and FY2024 results on March 4, 2025. Earnings report scheduled after market close. 2. Senior management to host a live conference call and webcast. Investors can access call via phone or web. 3. Announcement includes financial results disclosure and business update. Impact on performance will be reviewed.

3m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements are standard catalysts that can drive short-term volatility, yet typically the market has priced this event in similar historical cases.

How important is it?

Scheduled quarterly results can trigger short-term trading reactions. The event is closely watched but often anticipated.

Why Short Term?

Earnings releases cause immediate re-evaluation among traders, influencing short-term price movements.

Related Companies

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its fourth quarter and full year 2024 financial results after market close on Tuesday, March 4, 2025. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business. Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com. Contact for Investors & Media:  Investors:Rigel Pharmaceuticals, Inc.650.624.1232[email protected] Media:David Rosen Argot Partners Phone: 646.461.6387Email: [email protected] SOURCE Rigel Pharmaceuticals, Inc.

Related News